What is Rigel Pharmaceuticals's return on equity?

Rigel Pharmaceuticals (RIGL) reported return on equity of 174.1% in Q1 2026.

What is the long-term trend for Rigel Pharmaceuticals's return on equity?

Over 2 years (2020 to 2025), Rigel Pharmaceuticals's return on equity has grown at a 65.7% compound annual growth rate (CAGR), from -67.7% to 185.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Rigel Pharmaceuticals RIGL Return on equity

Return on equity at other companies

AmgenAMGN

101.3%-4.4pp

Agios PharmaceuticalsAGIO

-32.8%—

Nuvation BioNUVB

-39.5%-15.8pp

Zevra Therapeutics, Inc.ZVRA

100.7%+60.3pp

Gyre Therapeutics, Inc.GYRE

8.2%+4.2pp

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

net income/total stockholders equity=174.1%

Based on trailing twelve months.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's return on equity?: Rigel Pharmaceuticals (RIGL) reported return on equity of 174.1% in Q1 2026.
What is the long-term trend for Rigel Pharmaceuticals's return on equity?: Over 2 years (2020 to 2025), Rigel Pharmaceuticals's return on equity has grown at a 65.7% compound annual growth rate (CAGR), from -67.7% to 185.9%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.